The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
Hong Hong Regen Medtech Limited ("HKRM") is a newly established stem cell biotechnology company dedicated to developing regenerative medicine for intractable diseases. Through harnessing the therapeutic potential of stem cells, HKRM is developing new medicine targeting degenerative and immunological diseases. HKRM engineered stem cell manipulation and differentiation platform mimicking native developmental niches to generate high-quality cell therapy products.